Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron

Authors

Zhenlu Chong, Washington University School of Medicine in St. Louis
Courtney E Karl, Washington University School of Medicine in St. Louis
Peter J Halfmann, University of Wisconsin - Madison
Yoshihiro Kawaoka, University of Wisconsin - Madison
Emma S Winkler, Washington University School of Medicine in St. Louis
Shamus P Keeler, Washington University School of Medicine in St. Louis
Michael J Holtzman, Washington University School of Medicine in St. Louis
Jinsheng Yu, Washington University School of Medicine in St. Louis
Michael S Diamond, Washington University School of Medicine in St. Louis

Journal

Cell Reports

Publication Date

5-10-2022

Volume

39

Issue

6

First Page

110799

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2022.110799

Rights and Permissions

Chong Z, Karl CE, Halfmann PJ, Kawaoka Y, Winkler ES, Keeler SP, Holtzman MJ, Yu J, Diamond MS. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Rep. 2022 May 10;39(6):110799. doi: 10.1016/j.celrep.2022.110799. Copyright 2022 The Authors. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Recommended Citation

Chong, Zhenlu; Karl, Courtney E; Halfmann, Peter J; Kawaoka, Yoshihiro; Winkler, Emma S; Keeler, Shamus P; Holtzman, Michael J; Yu, Jinsheng; and Diamond, Michael S, "Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron." Cell Reports. 39, 6. 110799 (2022).
https://digitalcommons.wustl.edu/oa_4/1322

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.